TY  - RPRT
TI  - Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer
AU  - Schneider, B.
AU  - Boyer, A.
AU  - Ciccolini, J.
AU  - Barlesi, F.
AU  - Wang, K.
AU  - Benzekry, S.
AU  - Mochel, J. P.
PY  - 2019
DO  - 10.1101/540849
UR  - https://www.biorxiv.org/content/10.1101/540849v1
ID  - 10.1101/540849
ER  -